← ANALYSTS · TIPRANKS
Andrea Newkirk · Goldman Sachs
Hits
50%
7 of 14 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+29.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
14
Buy / hold / sell: 7 / 5 / 2
Upside of the analyst’s targets
+34.1%
Average over 14 current targets, to the last price
The market’s answer to the ratings
+2.8%
Day-0 move against SPY in the rating’s direction, average over 12 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 07:15 | UTHRUnited Therapeutics · $23.3B | Reiterated | Sell | $321 → $368+14.6% | −31.0% | 0.0%next day −0.4% | ↗ |
| Sep 30on TipRanks Oct 1 09:45 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Sell | $7.00 | −12.7% | +6.1%next day −5.3% · 5 days −12.0% | ↗ |
| Sep 29on TipRanks 21:10 | KODIWMKodiak Sciences · $5.5B | Reiterated | Hold | $36.00 → $103+186.1% | +20.1% | +4.2%next day +3.7% · 5 days −5.8% | ↗ |
| Sep 24on TipRanks Sep 25 02:35 | UTHRUnited Therapeutics · $23.3B | Initiated | Sell | $321 | −39.8% | −3.4%next day +0.1% · 5 days +21.4% | ↗ |
| Sep 24on TipRanks Sep 25 02:35 | MGTXIWMMeiragtx Holdings · $950M | Initiated | Hold | $16.00 | +72.4% | −5.9%next day −1.8% · 5 days −3.1% | ↗ |
| Sep 24on TipRanks 07:40 | ALKSIWMAlkermes · $6.7B | Initiated | Hold | $50.00 | +21.3% | −3.1%next day −0.4% · 5 days −0.2% | ↗ |
| Sep 24on TipRanks 06:30 | ARWRArrowhead Pharmaceuticals · $8.2B | Initiated | Hold | $74.00 | +32.4% | −1.2%next day −0.8% · 5 days −1.5% | ↗ |
| Sep 24on TipRanks 04:35 | INSMInsmed · $21.5B | Initiated | Buy | $188 | +95.3% | +2.8%next day −3.6% · 5 days −10.2% | ↗ |
| Sep 24on TipRanks 04:35 | TARSIWMTarsus Pharmaceuticals · $3.5B | Initiated | Buy | $116 | +70.4% | +2.3%next day −0.9% · 5 days −0.2% | ↗ |
| Sep 24on TipRanks 04:35 | KRYSIWMKrystal Biotech · $9.8B | Initiated | Buy | $441 | +39.3% | +1.0%next day −0.3% · 5 days −5.3% | ↗ |
| Sep 24on TipRanks 04:30 | JAZZJazz Pharmaceuticals · $13.9B | Initiated | Buy | $337 | +60.3% | +0.7%next day +0.2% · 5 days −1.0% | ↗ |
| Sep 24on TipRanks 04:30 | MDGLMadrigal Pharmaceuticals · $10.4B | Initiated | Buy | $704 | +56.5% | +0.1%next day +0.1% · 5 days −2.2% | ↗ |
| Sep 24on TipRanks 04:30 | RVMDRevolution Medicines · $41.5B | Initiated | Buy | $267 | +50.0% | +4.9%next day +2.0% · 5 days +3.4% | ↗ |
| Sep 24on TipRanks 03:25 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Initiated | Sell | $7.00 | −12.7% | −12.5%next day +0.9% · 5 days +3.3% | ↗ |
| Sep 24on TipRanks 03:20 | IOVAIWMIovance Biotherapeutics · $6.7B | Initiated | Buy | $15.00 | +10.1% | +6.1%next day +1.3% · 5 days +32.2% | ↗ |
| Nov 7on TipRanks 13:45 | SDGRIWMSchrodinger · $1.9B | Reiterated | Hold | $19.00 → $21.00+10.5% | −7.1% | −4.8%next day +1.3% · 5 days −0.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗